玩弄秘书的奶又大又软,99香蕉国产精品偷在线观看,日本japanese熟睡人妻,99香蕉国产精品偷在线观看

咨詢熱線

15000266580

當(dāng)前位置:首頁  >  技術(shù)文章  >  日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

更新時間:2013-07-26      點擊次數(shù):3200

   日本研究人員獲得批準(zhǔn),可以開展利用干細(xì)胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導(dǎo)AMD患者身上取下的皮膚細(xì)胞使其處于一種類似于干細(xì)胞的狀態(tài)后再將其轉(zhuǎn)至患者,以達(dá)到治療效果。

干細(xì)胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細(xì)胞領(lǐng)域的研究獲得諾貝爾獎。

詳細(xì)英文報道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
亚洲AV午夜精品一区二区三区| 色婷婷亚洲精品天天综合影院 | 丰满少妇大乳高潮在线| 中文字幕第一页| 日本被黑人强伦姧人妻完整版| 亚洲精品乱码久久久久久自慰| 我被脱个精光绑起来憋尿的作文| 国产亚洲精品久久久久久 | 亚洲AV无码AV吞精久久| 国自产拍偷拍精品啪啪| 久久久久精品| 被夫の上司に犯波多野结衣| 放荡人妇人妻出轨系列| 97人人爽人人爽乱码AV国产 | 亚洲精品乱码久久久久久| a片在线观看免费| 午夜精品一区二区三区免费视频| 久久久久久国产精品MV| 亚洲欧美成人无码久久久| 人妻无码久久中文字幕专区| 人妻av无码专区久久绿巨人| 复读生与应届生高考录取有区别吗| 最近更新2019中文字幕7| 久久99国产综合精品| 狠狠综合久久无码AV网站| 无码一区二区三区中文字幕| 无码国产精品成人午夜视频| 国产精品自产拍高潮在线观看| 最近中文字幕免费MV视频7| 欧美性生交XXXXX久久久| AV在线免费观看| 日本精品无码一区二区三区久久久 | 日日噜噜夜夜狠狠久久丁香五月| 精品久久人人爽天天玩人人妻| 波兰小妓女BBWBBW| 男人的天堂AV| 小伙与熟女50岁HD| 欧美乱妇狂野欧美在线视频| 国产精品99久久久久久| 亚洲精品无码乱码成人| 亚洲人成亚洲人成在线观看|